More News

17 Jun 2019 Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives
17 Jun 2019 Pfizer to Acquire Array BioPharma
13 Jun 2019 AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
12 Jun 2019 Sobi acquires emapalumab and related assets
11 Jun 2019 Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
11 Jun 2019 BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan
10 Jun 2019 Merck to Acquire Tilos Therapeutics
07 Jun 2019 Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics
03 Jun 2019 Vical and Brickell Announce Merger Agreement
31 May 2019 ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
30 May 2019 Amicus Therapeutics and the University of Pennsylvania Announce Major Expansion of Gene Therapy Collaboration
30 May 2019 Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
29 May 2019 Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive Worldwide License Agreement for the Treatment of MPS-I
29 May 2019 Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
29 May 2019 Ziopharm Oncology Announces Exclusive License with National Cancer Institute to Identify and Use T-Cell Receptors Targeting Neoantigens for Cancer with Sleeping Beauty Platform
28 May 2019 Sensorion Announces the Signature of a Partnership Framework Agreement with Institut Pasteur on Gene Therapy Programs Targeting Hearing Loss
24 May 2019 FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma NovoTTF-100L, a Tumor Treating Fields delivery system, is the first FDA-approved mesothelioma treatment in more than 15 years In
21 May 2019 Evotec jump-starts biologics with acquisition of Just Biotherapeutics
21 May 2019 Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
21 May 2019 CureVac Enters into an Exclusive Sponsored Research Agreement for Discovery Research in mRNA-based Eye Therapy Candidates with the Schepens Eye Research Institute, Harvard Medical School and the Massachusetts Eye and Ear Infirmary
21 May 2019 Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse
18 May 2019 Ligand Licenses VER250840 to Cumulus Oncology
16 May 2019 Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating Lymphocyte) Products
16 May 2019 HDL Therapeutics Announces Positive Data From Registration Trial of PDS-2™ System in Homozygous Familial Hypercholesterolemia
16 May 2019 ASC Therapeutics Licenses Critical Technologies for Hemophilia A Gene Therapy from Expression Therapeutics

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up